1-3 of 3
Jolie Schafer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I, Single-Arm, Open Label, Dose Escalation, Multicenter Study of Off-the-Shelf Natural Killer (NK) Cells (SAR445419) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

Marina Y. Konopleva, Vijaya Raj Bhatt, Ioannis Mantzaris, Abhishek Maiti, Krishna Gundabolu, Kyle Jensen, Jolie Schafer, Gu Mi, Agata Drewniak, Heidi Krenz, Rao Saleem, Giovanni Abbadessa, Naval Daver
Journal: Blood
Blood (2023) 142 (Supplement 1): 5972.
https://doi.org/10.1182/blood-2023-174030
Published: 2023
Journal Articles

Haploidentical Mbil-21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Multiple Relapsed and Refractory Acute Myeloid Leukemia

Stefan O. Ciurea, MD, Jolie Schafer, Piyanuch Kongtim, MD, Julianne Chen, Doris Soebbing, Kai Cao, MS, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Marina Konopleva, MD PhD, Dean Anthony Lee, MD PhD, Richard E. Champlin, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 11–12.
https://doi.org/10.1182/blood-2020-134858
Published: 2020
Journal Articles

Safety and Feasibility of Administration of High Doses of Ex Vivo Expanded NK Cells for Prevention of Disease Relapse after Transplantation for Patients with Myeloid Malignancies - Final Results of a Phase I Clinical Trial

Stefan O. Ciurea, MD, Dean A. Lee, MD PhD, Cecele Denman, MS, Jolie Schafer, Roland L Bassett, Jr., Kai Cao, MS, MD, Gabriela Rondon, MD, Julianne Chen, Doris Soebbing, Dana B. Willis, Sairah Ahmed, MD, Qaiser Bashir, MD, Partow Kebriaei, MD, Issa F. Khouri, MD, Betul Oran, MD, Simrit Parmar, MD, Uday R. Popat, MD, Chitra Hosing, MD, Eric Yvon, PhD, Katayoun Rezvani, MD PhD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2016) 128 (22): 500.
https://doi.org/10.1182/blood.V128.22.500.500
Published: 2016